MetaCap

Aclaris Therapeutics (ACRS) News

NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.44-0.06 (-1.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ACRS news summary

We found 16 recent headlines mentioning Aclaris Therapeutics (ACRS): 6 in the past week and 14 in the past 30 days, most often from Nasdaq, GlobeNewswire, Investing.com. For price context, ACRS is down 1.71% at $3.44. The most recent story, "Why is Aclaris Therapeutics stock sliding today?", was published by Investing.com on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Aclaris Therapeutics headlines

Stocks mentioned alongside ACRS

Compare ACRS